These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24739601)

  • 1. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.
    Endo A; Yoshida Y; Kageshima K; Sato H; Suga T; Nasu H; Takahashi N; Tanabe K
    Intern Med; 2014; 53(8):819-28. PubMed ID: 24739601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
    Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
    J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different effects of inflammation and lipid levels on coronary lesions after PCI].
    Xu HY; Qiao SB; Li JJ; Yang YJ; Zhang JF; Xu B; Xie GQ; Dong QT
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2249-52. PubMed ID: 20095335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.
    Matsumoto I; Miyake Y; Mizukawa M; Takagi Y
    Circ J; 2011; 75(4):905-10. PubMed ID: 21325724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
    Ren X; Wang X
    Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions.
    Hasegawa S; Nakano T; Mukai Y; Matsukuma Y; Yotsueda R; Tsuchimoto A; Fujisaki K; Tsuruya K; Tsutsui H; Kitazono T
    Ther Apher Dial; 2021 Jun; 25(3):296-303. PubMed ID: 32643821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
    Farkouh ME; Godoy LC; Brooks MM; Mancini GBJ; Vlachos H; Bittner VA; Chaitman BR; Siami FS; Hartigan PM; Frye RL; Boden WE; Fuster V
    J Am Coll Cardiol; 2020 Nov; 76(19):2197-2207. PubMed ID: 33153578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
    Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
    J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
    Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
    Nagata I; Ike A; Nishikawa H; Zhang B; Sugihara M; Mori K; Iwata A; Kawamura A; Shirai K; Uehara Y; Ogawa M; Miura S; Saku K
    J Cardiol; 2015 Feb; 65(2):105-11. PubMed ID: 24997801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.
    Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J
    Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.